KVUE Kenvue Inc.
Consumer Defensive · Household & Personal Products
19.05
+0.11%
About the company
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
52-week range
Dividend deep dive
Kenvue Inc. (KVUE), operating in the Household & Personal Products industry within the Consumer Defensive sector, currently offers a dividend yield of 4.39% in USD. This yield is notably higher than its 5-year average yield of 3.86% and also exceeds its 5-year high of 4.05%. While Yield Theory suggests Kenvue may be undervalued with an implied price of 21.5 USD, its dividend safety is categorized as "watch".
Dividend history
Kenvue has a short history of dividend increases, with a streak of 2 consecutive years. The company's annual dividend per share has increased from 0.8 USD in 2023 to 0.81 USD in 2024, and further to 0.826 USD projected for 2025. This indicates consistent, albeit modest, annual growth since its public offering. Specific 3-year and 5-year dividend Compound Annual Growth Rates (CAGRs) are not available in the provided data. Dividends are paid quarterly.
Dividend safety
Kenvue's dividend coverage appears stretched, with a payout ratio of 98.81% based on its 0.83 USD annual dividend and 0.84 USD EPS. The company's leverage, indicated by a debt-to-equity ratio of 82.975, is notable.
Quantic · Free
Read the rest of the safety verdict
Plus the key risks and what to watch next — free, no card.
AI-generated from Quantic's dividend data · Updated 17 Jul 2026 · Information, not financial advice.
Price history
Dividend profile
Yield band A stock's current dividend yield shown against its own range over the past five years — the low, average and high. Near the high end the shares look relatively cheap for the income they pay; near the low end, relatively expensive. It's the picture behind Dividend Yield Theory. Learn more → (5-year)
Payment calendar
Dividend history
Per-share dividend by year
Debt & leverage
Latest reported balance-sheet figures.
Held by 3 investors · watched by 1
Appears in these lists
KVUE qualifies for these curated dividend rankings.
New to dividend investing?
Information, not financial advice.
Quantic · Free
Track KVUE and your whole portfolio
Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →